Patient Capital And Regulatory Resolve: Dr Reddy’s Chief On Building India's Innovation Backbone

Pharma Intelligence Podcasts

In this podcast, Satish Reddy, chairman of Dr. Reddy's Laboratories, talks about deploying generic Revlimid gains strategically, building a diversified growth engine, what India must fix — regulatory science, risk capita...View more